Related Experiment Videos
Barrett's oesophagus: results from a 13-year surveillance programme
K Bani-Hani1, H Sue-Ling, D Johnston
1Division of Surgery, University of Leeds, The Centre for Digestive Diseases, The General Infirmary at Leeds, UK.
European Journal of Gastroenterology & Hepatology
|July 27, 2000
Summary
This study found a higher incidence of esophageal adenocarcinoma in male patients with Barrett's esophagus and specialized epithelium. Routine surveillance is recommended for this high-risk group to detect cancer early.
Area of Science:
- Gastroenterology
- Oncology
- Esophageal Diseases
Background:
- Barrett's esophagus is a known risk factor for esophageal adenocarcinoma.
- The precise magnitude of this cancer risk remains debated.
- Surveillance programs aim to detect early-stage cancer in high-risk individuals.
Purpose of the Study:
- To determine the incidence of esophageal adenocarcinoma in patients with Barrett's esophagus.
- To evaluate the effectiveness of a 13-year surveillance program.
- To identify specific patient groups at higher risk for cancer development.
Main Methods:
- Retrospective analysis of patient records from a 13-year surveillance program.
- Inclusion of patients with histologically confirmed Barrett's esophagus.
- Yearly endoscopy and biopsy surveillance for a subset of patients.
Main Results:
- 12 cases of esophageal adenocarcinoma were diagnosed over a mean follow-up of 43 months.
- Higher cancer incidence observed in men (1 per 69 patient-years) compared to women (1 per 537 patient-years).
- Patients with specialized epithelium showed a significant cancer incidence (1 per 95 patient-years).
Conclusions:
- Routine surveillance is supported for male patients with Barrett's esophagus and specialized epithelium.
- The findings highlight a significant sex-based difference in cancer risk.
- Further research may clarify the optimal screening strategies for Barrett's esophagus.